Krystal Biotech, Inc. Common Stock (KRYS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for KRYS. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 4,181,432 | $1.6B | INCREASED |
| State Street | 1,351,158 | $502M | INCREASED |
| Vestor Capital | 700,914 | $78M | INCREASED |
| Principal Financial Group | 169,550 | $63M | INCREASED |
| BNY Mellon | 163,610 | $61M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| John Charles Thomas (EVP, General Counsel) | EXERCISE | 1,000 | $179K | 2026-06-25 |
| John Charles Thomas (EVP, General Counsel) | SELL | 1,000 | $347K | 2026-06-25 |
| Krish S Krishnan (President and CEO) | SELL | 40 | $12K | 2026-06-04 |
| Krish S Krishnan (President and CEO) | SELL | 964 | $300K | 2026-06-04 |
| Krish S Krishnan (President and CEO) | SELL | 2,652 | $823K | 2026-06-04 |
Full institutional holdings, insider history, and congressional trades for Krystal Biotech, Inc. Common Stock on SentiSense.